TrialAdvances in therapy2018

A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects.

Ippei Ikushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.